Structure Therapeutics Inc. Operating Lease, Payments
Structure Therapeutics Inc. (GPCR) reported Operating Lease, Payments of $1.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-06
- Structure Therapeutics Inc. operating lease, payments for the quarter ending 2026-06-30 was $1.00M, a 25.00% increase year-over-year.
- Structure Therapeutics Inc. operating lease, payments for the quarter ending 2026-03-31 was $800.00K, a 33.33% increase year-over-year.
- Structure Therapeutics Inc. operating lease, payments for the quarter ending 2025-12-31 was $800.00K, a 100.00% increase year-over-year.
- Structure Therapeutics Inc. operating lease, payments for the quarter ending 2025-09-30 was $700.00K, a 40.00% increase year-over-year.
- Structure Therapeutics Inc. operating lease, payments for fiscal 2025 was $2.90M, a 70.59% increase from fiscal 2024.
- Structure Therapeutics Inc. operating lease, payments for fiscal 2024 was $1.70M, a 183.33% increase from fiscal 2023.
- Structure Therapeutics Inc. operating lease, payments for fiscal 2023 was $600.00K, a 50.00% increase from fiscal 2022.
- Structure Therapeutics Inc. operating lease, payments for fiscal 2022 was $400.00K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.80M 10-Q · filed 2026-08-06 | $2.60M derived: sum of 3 quarters · filed 2026-08-06 | $3.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $800.00K 10-Q · filed 2026-05-07 | $1.60M derived: sum of 2 quarters · filed 2026-05-07 | $2.30M derived: sum of 3 quarters · filed 2026-05-07 | $3.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.50M derived: sum of 2 quarters · filed 2026-02-26 | $2.30M derived: sum of 3 quarters · filed 2026-08-06 | $2.90M 10-K · filed 2026-02-26 |
| 2025-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.50M derived: sum of 2 quarters · filed 2026-08-06 | $2.10M 10-Q · filed 2025-11-06 | $2.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.40M 10-Q · filed 2026-08-06 | $1.80M derived: sum of 3 quarters · filed 2026-08-06 | $2.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $600.00K 10-Q · filed 2026-05-07 | $1.00M derived: sum of 2 quarters · filed 2026-05-07 | $1.50M derived: sum of 3 quarters · filed 2026-05-07 | $2.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $900.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.40M derived: sum of 3 quarters · filed 2026-02-26 | $1.70M 10-K · filed 2026-02-26 |
| 2024-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.00M derived: sum of 2 quarters · filed 2025-11-06 | $1.30M 10-Q · filed 2025-11-06 | $1.70M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $800.00K 10-Q · filed 2025-08-06 | $1.20M derived: sum of 3 quarters · filed 2026-02-26 | $1.20M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $300.00K 10-Q · filed 2025-05-08 | $700.00K derived: sum of 2 quarters · filed 2026-02-26 | $700.00K derived: sum of 3 quarters · filed 2026-02-26 | $800.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $400.00K derived: sum of 2 quarters · filed 2026-02-26 | $500.00K derived: sum of 3 quarters · filed 2026-02-26 | $600.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $100.00K derived: sum of 2 quarters · filed 2024-11-13 | $200.00K 10-Q · filed 2024-11-13 | $300.00K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $200.00K 10-Q · filed 2024-08-08 | $300.00K derived: sum of 3 quarters · filed 2024-08-08 | $400.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-09 | $200.00K derived: sum of 2 quarters · filed 2024-05-09 | $300.00K derived: sum of 3 quarters · filed 2024-05-09 | $400.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $200.00K derived: sum of 2 quarters · filed 2024-03-08 | $300.00K derived: sum of 3 quarters · filed 2024-03-08 | $400.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | $100.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-11-17 | $200.00K derived: sum of 2 quarters · filed 2023-11-17 | $300.00K 10-Q · filed 2023-11-17 | |
| 2022-06-30 | $100.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-11-17 | $200.00K 10-Q/A · filed 2023-11-17 | ||
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |